ask="44.50"
ask_size="2400"
average_daily_volume="1099030"
bid="41.65"
bid_size="2500"
book_value="4.05"
change="-0.61"
change_from_200_day_moving_average="-4.69"
change_from_50_day_moving_average="0.07"
change_from_52_week_high="-13.62"
change_From_52_week_low="9.35"
change_in_percent="-1.45%"
close="41.53"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.68"
eps_estimate_next_quarter="-0.48"
eps_estimate_next_year="-2.05"
ex_dividend_date="N/A"
float_shares="85678000"
high="42.59"
high_52_weeks="55.15"
last_trade_date="2/14/2017"
last_trade_price="41.53"
last_trade_size="61684"
last_trade_time="4:00pm"
low="40.57"
low_52_weeks="32.18"
market_capitalization="3.61B"
moving_average_200_day="46.22"
moving_average_50_day="41.46"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="67.00"
open="42.10"
pe_ratio="N/A"
peg_ratio="0.69"
percent_change_from_200_day_moving_average="-10.15%"
percent_change_from_50_day_moving_average="+0.18%"
percent_change_from_52_week_high="-24.70%"
percent_change_from_52_week_low="+29.06%"
previous_close="42.14"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.41"
price_per_sales="244.05"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.01"
stock_exchange="NMS"
symbol="NBIX"
volume="1275170"
weeks_range_52="32.18 - 55.15"
